Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

The stereological investigation of conditioned medium originated from human adipose tissue-derived mesenchymal stem cells and platelet-rich plasma effects on polycystic ovary syndrome in a rat model.

Dehghani F., Arefnezhad R., Tanideh N., Karimi F., Aliakbari F., Mohseni G.

Animal Study on Scar, published in Zygote (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Zygote (2025)
Country
England
Reported sample size
—
Source database
PubMed
PMID
40988384
DOI
10.1017/S0967199425100142

Abstract (original English)

Platelet-rich plasma (PRP) and conditioned medium (CM) originating from human adipose tissue mesenchymal stem cells (ATMSCs) as two enriched sources of growth factors have a potential impact on tissue repair. This investigation aimed to investigate the effects of PRP and CM on ovarian structures in letrozole-induced polycystic ovarian syndrome (PCOS) in female rats through the stereological methods. To obtain PRP, blood samples from Wistar rats were collected in citrate tubes, centrifuged (400g, 10 min) to separate components. Plasma+Buffy coat was recentrifuged (800g, 10 min); Platelet-poor-plasma (PPP) discarded, PRP (lower layer) obtained and stored at - 20°C. To attain the mentioned mesenchymal CM, first, adipose tissue was collected from liposuction samples by collagenase digestion and cultured in DMEM/FBS. To approve the isolation of ATMSCs, the flow cytometry method, based on the expression status of CD44, CD90, CD34 and CD45 markers, was carried out. ATMSCs were then grown in serum-free DMEM, and supernatant was centrifuged and stored. Forty female Wistar rats were allocated into five groups (Control, negative control (letrozole [LTZ]), letrozole and PRP [LTZ-PRP], letrozole and CM [LTZ-CM] and letrozole and PRP + CM [LTZ-PRP + CM] groups). The Control group received normal saline (0.9% NaCl, 200 μl) orally. In the negative control, PCOS was induced by letrozole (1 mg/k

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
FemaleAnimalsPolycystic Ovary SyndromePlatelet-Rich PlasmaMesenchymal Stem CellsRats, WistarHumansAdipose TissueCulture Media, ConditionedLetrozole

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research